NCT02195492已完成不适用
Synvisc® in With Knee Osteoarthritis: Retrospective Follow-up in Active Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
- 主要终点
- Amount of medication consumed
研究概览
简要总结
Retrospective collection of data, aimed at a better knowledge of the context of use of Synvisc® among the patients practising a regular activity (professional/leisure), and at evaluating the different practices and their results.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •use of Synvisc®
- •patients practising a regular activity (professional/leisure)
排除标准
- 未提供
研究组 & 干预措施
Synvisc®
干预措施: Synvisc® (Drug)
结局指标
主要结局
Amount of medication consumed
时间窗: up to 1 year
antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs)
次要结局
- Patient-assessed benefit on a 2-point verbal rating scale(up to 1 year)
研究者
相似试验
已完成
不适用
Retrospective Follow-up Study of Synvisc® in Patients With Knee OsteoarthritisOsteoarthritisNCT02195557Boehringer Ingelheim16
已完成
不适用
Use of Synvisc® in Knee Osteoarthritis - Survey on PracticeOsteoarthritisNCT02195544Boehringer Ingelheim70
已完成
不适用
Use of Synvisc® in Knee Osteoarthritis - Medico-economical StudyOsteoarthritisNCT02195505Boehringer Ingelheim374
已完成
3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle OsteoarthritisOsteoarthritisNCT00131768Genzyme, a Sanofi Company
已完成
3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisMusculoskeletal DiseasesOsteoarthritisNCT00131300Genzyme, a Sanofi Company